Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Stem Cell Reports
|
February 24, 2015
Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin
Thomas Höfner, Christian Eisen, Corinna Klein, et al.
BJU International
|
October 10, 2020
Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study
Shiva M Nair, Gencay Hatiboglu, James Relle, et al.
The Journal of Urology
|
October 22, 2011
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion
Boris A Hadaschik, Timur H Kuru, Corina Tulea, et al.
Translational Oncology
|
December 23, 2015
Prognostic Significance and Functional Role of CEP57 in Prostate Cancer
Josef Mang, Nina Korzeniewski, Dimo Dietrich, et al.
World Journal of Urology
|
August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series
Sabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
European Urology
|
January 22, 2014
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design
Willemien van den Bos, Berrend G Muller, Hashim Ahmed, et al.
The Journal of Urology
|
February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model
Matthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
BJU International
|
July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)
Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
European Urology
|
January 19, 2016
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial
Joseph L Chin, Michele Billia, James Relle, et al.
Kidney International
|
July 31, 2014
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad, Fabian Bock, Wei Dong, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Stem Cell Reports
|
February 24, 2015
Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin
Thomas Höfner, Christian Eisen, Corinna Klein, et al.
BJU International
|
October 10, 2020
Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study
Shiva M Nair, Gencay Hatiboglu, James Relle, et al.
The Journal of Urology
|
October 22, 2011
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion
Boris A Hadaschik, Timur H Kuru, Corina Tulea, et al.
Translational Oncology
|
December 23, 2015
Prognostic Significance and Functional Role of CEP57 in Prostate Cancer
Josef Mang, Nina Korzeniewski, Dimo Dietrich, et al.
World Journal of Urology
|
August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series
Sabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
European Urology
|
January 22, 2014
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design
Willemien van den Bos, Berrend G Muller, Hashim Ahmed, et al.
The Journal of Urology
|
February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model
Matthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
BJU International
|
July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)
Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
European Urology
|
January 19, 2016
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial
Joseph L Chin, Michele Billia, James Relle, et al.
Kidney International
|
July 31, 2014
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad, Fabian Bock, Wei Dong, et al.
Page
of 13